<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38766119</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>May</Month><Day>10</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>Activity-dependent FosB gene expression negatively regulates mast cell functions.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2024.05.06.592755</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2024.05.06.592755</ELocationID><Abstract><AbstractText>Mast cells are innate immune cells that play a crucial role in numerous physiological processes across tissues by releasing pre-stored and newly synthesized mediators in response to stimuli, an activity largely driven by changes in gene expression. Given their widespread influence, dysfunction in mast cells can contribute to a variety of pathologies including allergies, long COVID, and autoimmune and neuroinflammatory disorders. Despite this, the specific transcriptional mechanisms that control mast cell mediator release remain poorly understood, significantly hindering the development of effective therapeutic strategies. We found that the two proteins encoded by the transcription factor FosB, FOSB and the highly stable variant &#x394;FOSB, are robustly expressed upon stimulation in both murine and human mast cell progenitors. Motivated by these findings, we generated a novel mouse model with targeted ablation of FosB gene expression specifically in mast cells (MC <sup>FosB-</sup> ) by crossing a mast cell-specific Cre reporter line (Mcpt5-Cre) with a Cre-dependent floxed FosB mouse lines. We found that mast cell progenitors derived from MC <sup>FosB-</sup> mice, compared to wild types (WT), exhibit baseline increased histamine content and vesicle numbers. Additionally, they show enhanced calcium mobilization, degranulation, and histamine release following allergy-related IgE-mediated stimulation, along with heightened IL-6 release in response to infection-like LPS stimulation. <i>In vivo</i> experiments with IgE- mediated and LPS challenges revealed that MC <sup>FosB-</sup> mice experience greater drops in body temperature, heightened activation of tissue-resident mast cells, and increased release of pro-inflammatory mediators compared to their WT counterparts. These findings suggest that FosB products play a crucial regulatory role in moderating stimulus-induced mast cell activation in response to both IgE and LPS stimuli. Lastly, by integrating CUT&amp;RUN and RNAseq data, we identified several genes targeted by &#x394;FOSB that could mediate these observed effects, including Mir155hg, CLCF1, DUSP4, and Trib1. Together, this study provides the first evidence that FOSB/&#x394;FOSB modulate mast cell functions and provides a new possible target for therapeutic interventions aimed at ameliorating mast cell-related diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duque-Wilckens</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-3700-2600</Identifier></Author><Author ValidYN="Y"><LastName>Maradiaga</LastName><ForeName>Nidia</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Szu-Ying</LastName><ForeName>Yeh</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-4506-5652</Identifier></Author><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>Dimitry</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Srinavasan</LastName><ForeName>Vidhula</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Thelen</LastName><ForeName>Kyan</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Sotomayor</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Durga</LastName><ForeName>Kait</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Nestler</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Moeser</LastName><ForeName>Adam J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Robison</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>20</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38766119</ArticleId><ArticleId IdType="pmc">PMC11100602</ArticleId><ArticleId IdType="doi">10.1101/2024.05.06.592755</ArticleId><ArticleId IdType="pii">2024.05.06.592755</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>